Minimally Invasive Surgical Instrument Market Size & Share 2026-2035

Minimally Invasive Surgical Instrument Market Size

The global minimally invasive surgical instrument market was estimated at USD 31.6 billion in 2025. The market is expected to grow from USD 34.7 billion in 2026 to USD 66.1 billion in 2035, at a CAGR of 7.4% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors such as surging demand for minimally invasive procedures, growing adoption of robotic-assisted surgeries, technological advancements in surgical instruments, and increasing prevalence of chronic diseases, among other factors.
 

An aging population is driving surgical volumes, a rising trend of outpatient surgeries in developed markets, and supportive government initiatives are expected to fuel the industry's growth. Johnson & Johnson MedTech, Medtronic, OLYMPUS, INTUITIVE, Stryker, and Boston Scientific are among the leading players operating in the market. These players mainly focus on product innovation, geographic expansion, adoption of the latest technologies in devices, and collaboration with local or regional healthcare providers, among others.
 

The market has increased from USD 22.4 billion in 2022 and reached USD 28.6 billion in 2024, with a historic growth rate of 12.9%. The increasing prevalence of chronic diseases serves as the primary catalyst for market expansion, with epidemiological research indicating a continuing increase in surgical intervention for many different types of chronic illnesses. Chronic conditions such as cardiovascular diseases, cancer, diabetes, and chronic respiratory conditions collectively affect over 1.2 billion individuals globally. For instance, according to the data published by the Centers for Disease Control and Prevention (CDC), more than 0.9 million cardiovascular disease-related deaths were reported in the U.S. in 2023. Many of these conditions can be treated surgically; surgical procedures often use minimally invasive ways of performing surgery, such as cardiac catheterization, tumor removal, bariatric surgery, and orthopedic reconstruction, among others, supporting the market growth.
 

Additionally, recent advancements in technology within instruments used in surgery are resulting in expanded uses and options for the application of minimally invasive techniques throughout all areas of surgical practice. The use of haptic feedback technology has improved surgeons' ability to feel what they are performing to a much greater degree than previously available. The development of disposable advanced energy devices has improved sterility assurance while maintaining cost-effectiveness for healthcare facilities. A range of upcoming technology developments may allow certain procedures to be performed using minimally invasive techniques which were earlier performed as open surgeries, propelling the number of surgical procedures.
 

Further, the widespread acceptance of robotic-assisted surgeries has shifted from a availability in few select institutions to now performed in the vast majority of health systems in developed countries. As a result, there has been a substantial increase in the number of robotic surgical systems being purchased throughout the world. One of the key reasons for this increase in utilization is because all robotic systems provide unparalleled levels of accuracy, tremor filtration, motion scaling, and better ergonomics for the surgeons, especially in long procedures that require focused attention over long periods. Furthermore, the number of surgical specialties that now use robots has increased to include thoracic surgery, surgical oncology, otolaryngology, colorectal surgery, and even highly complex gynaecological procedures. Thus, due to this surge in range of uses, there is a growing demand for specialty instruments designed specifically for robotic systems.
 

Minimally invasive surgical instruments are specialized tools designed for performing surgical procedures through small incisions or natural body openings. These instruments enable surgeons to access and visualize internal organs or structures with minimal disruption to surrounding tissues.

Minimally Invasive Surgical Instrument Market Trends

Technological innovations in electrosurgical and energy devices, expansion of telesurgery and remote-assisted operations, and integration of AI and machine learning in surgical visualization are among the key trends shaping market growth positively.
 

• Advanced bipolar energy platforms now provide precise tissue sealing with minimal collateral thermal damage, utilizing sophisticated feedback mechanisms that monitor tissue impedance in real-time and automatically adjust energy delivery to optimize sealing performance.
   
• In addition, advanced energy systems combine radiofrequency energy, ultrasonic technology, and mechanical compression into unified devices that automatically select optimal energy parameters based on tissue characteristics and intended surgical effect.
   
• Additionally, the integration of artificial intelligence and machine learning capabilities into surgical visualization systems represents a transformative trend with the potential to alter surgical decision-making, procedural precision, and the accessibility of complex surgical techniques to broader surgeon populations.
   
• Further, remote surgical assistance platforms now enable expert surgeons to provide real-time guidance during complex procedures performed at distant facilities, effectively extending specialist expertise to underserved regions lacking local access to subspecialized surgical care.
   

Minimally Invasive Surgical Instrument Market Analysis

In 2022, the market was valued at USD 22.4 billion and grew to USD 25.7 billion in 2023, reaching USD 28.6 billion by 2024. Increased awareness and rise in surgical volume are key factors contributing to industry growth.
 

Based on product, the minimally invasive surgical instrument market is segmented into handheld instruments, monitoring & visualization devices, surgical scopes, inflation devices, cutter instruments, guiding devices, auxiliary devices, and electrosurgical devices. The handheld instruments segment accounted for a leading share of 23.7% in 2025. Growing focus on disposable and infection-free instruments is anticipated to fuel segmental growth. The segment is expected to reach USD 15.5 billion by 2035, growing at a CAGR of 7.3% during the forecast period.
 

• The primary tools of minimally invasive surgery include laparoscopic graspers, dissectors, scissors, needle holders, and other specialty instruments for specific anatomy.
   
• Handheld instrument innovation is serving to improve the ergonomics of devices, provide more articulation to allow access to hard-to-reach areas of anatomy, and use more advanced materials (such as titanium alloys and advanced polymers) to reduce weight and fatigue associated with long surgical procedures.
   
• Additionally, these devices are expected to continue to be in high demand as they can be used in almost every type of minimally invasive procedure and may allow for the development of more specialized instruments as minimally invasive surgical approaches expand into new areas of anatomy and clinical practice.
   
• The monitoring and visualization devices segment is anticipated to record the fastest growth with a robust 8% CAGR over the forecast period.
   
• The adoption of 4K and emerging 8K ultra-high-definition visualization systems provides unprecedented image clarity, particularly valuable during procedures requiring fine dissection near critical structures.
   
• Further, the integration of advanced image processing, including contrast enhancement, digital zoom, and video recording with automated documentation capabilities, adds substantial value to modern visualization systems beyond basic image capture.
   
• Furthermore, powered surgical staplers for gastrointestinal anastomosis and tissue transection represent high-value products within the cutter instruments category. In addition, inflation devices address the specific requirement of maintaining pneumoperitoneum during laparoscopic procedures, encompassing CO₂ insufflators with sophisticated pressure monitoring and gas flow regulation.
   

Based on surgery type, the minimally invasive surgical instrument market is segmented into cardiothoracic surgery, orthopedic surgery, gastrointestinal surgery, urological surgery, gynecological surgery, cosmetic & bariatric surgery, and other surgery types. The cardiothoracic surgery segment accounted for a leading share and was valued at USD 7.5 billion in 2025.
 

• Minimally invasive cardiac surgery typically utilizes small thoracotomy incisions rather than median sternotomy, avoiding the prolonged healing time, infection risks, and functional limitations associated with traditional sternotomy approaches.
   
• Additionally, robotic-assisted platforms have proven particularly valuable in cardiothoracic applications where three-dimensional visualization and articulating instruments enable precise suturing in confined spaces, leading to the majority of mitral valve repairs being performed robotically.
   
• The orthopedic surgery segment represents the highest CAGR at 8.1%, reflecting rapid adoption of minimally invasive techniques across multiple orthopedic subspecialties.
   
• Arthroscopic procedures for sports medicine applications, including ACL reconstruction, meniscal repair, and rotator cuff surgery, have achieved significant adoption in developed markets, with ongoing innovations in suturing techniques and biological augmentation strategies driving continued market growth.
   
• Further, bariatric surgery has emerged as a substantial growth driver within gastrointestinal surgery, with rising global obesity prevalence driving demand for surgical weight loss interventions.
   
• Lastly, the expansion of endoscopic bariatric techniques, including intragastric balloons, endoscopic sleeve gastroplasty, and endoscopic revision of surgical procedures, result in additional market opportunities.

Based on end use, the minimally invasive surgical instrument market is segmented into hospitals & clinics, ambulatory surgical centers and other end-users. The hospitals & clinics segment accounted for the leading market share of 56.5% in 2025.
 

• Hospitals and clinics dominate the market due to their advanced infrastructure and ability to handle complex procedures. Complex revisions and deformity corrections, as well as procedures involving patients who require extended support and monitoring, are typically performed by hospitals or specialty clinics.
   
• They invest heavily in robotic-assisted systems, electrosurgical devices, and high-end visualization tools to improve surgical precision and patient outcomes. These facilities cater to a wide range of surgeries, including orthopedic, cardiac, and gastrointestinal surgeries, making them the major revenue-generating segment.
   
• Additionally, hospitals often serve as training centers for MIS techniques, further driving demand for cutting-edge instruments and integrated digital solutions.
   
• The ambulatory surgical centers segment was valued at USD 10 billion in 2025. ASCs are rapidly emerging as a key growth segment in the MIS instrument market, driven by the rising preference for outpatient procedures.
   
• Further, they offer cost-effective surgical solutions with shorter recovery times, attracting patients seeking convenience and affordability. ASCs primarily focus on high-volume, low-complexity surgeries such as laparoscopic, orthopedic, and urological procedures.
   
• Moreover, the segment benefits from favorable reimbursement policies and growing healthcare decentralization, making it a critical driver of MIS expansion in developed and emerging markets.

North America Minimally Invasive Surgical Instrument Market

North America minimally invasive surgical instrument market accounted for a majority share of 39.5% in 2025 in the market and is anticipated to show notable growth over the forecast period.
 

• The U.S. market was valued at USD 8.2 billion and USD 9.4 billion in 2022 and 2023, respectively. In 2025 the market size was valued at USD 11.6 billion from USD 10.5 billion in 2024. Rising trend of outpatient surgeries in developed markets is projected to fuel the market growth.
   
• The regional market growth is supported by highest per-capita healthcare expenditure globally, sophisticated reimbursement infrastructure supporting technology adoption, and early adoption of innovative medical technologies.
   
• In addition, the U.S. market benefits from robust private insurance and Medicare coverage for minimally invasive procedures across most surgical specialties.
   
• Further, provincial health authorities increasingly recognize total cost-of-care advantages of minimally invasive approaches when accounting for reduced hospital days, supporting investment in enabling infrastructure.
   

Europe Minimally Invasive Surgical Instrument Market

Europe accounted for a significant share of the market and was valued at USD 9.2 billion in 2025.
 

• European regulatory frameworks such as the Medical Device Regulation create rigorous oversight of surgical instruments, potentially slowing commercialization of innovations but providing quality assurance that supports clinician and patient confidence.
   
• Growing attention to environmental sustainability in European healthcare may influence purchasing decisions, potentially favoring reusable instrument systems over disposable alternatives in price-sensitive segments.
   
• Further, the establishment of specialized minimally invasive surgery centers of excellence in the UK within the NHS has driven skill development and technology adoption across the system.
   

Asia Pacific Minimally Invasive Surgical Instrument Market

The Asia Pacific minimally invasive surgical instrument industry accounted for a substantial share of the market and was valued at USD 6.7 billion in 2025.
 

• The Asia-Pacific region encompasses substantial diversity, including developed markets (Japan, South Korea, Australia), rapidly developing large-population economies (China, India), and emerging Southeast Asian nations at varying stages of healthcare infrastructure development.
   
• The Chinese government's Healthy China 2030 initiative explicitly targets expanded access to advanced medical technologies and improved surgical capabilities in secondary and tertiary hospitals throughout the country.
   
• Further, cultural factors, including patient preferences for less visible scarring and shorter hospital stays, align well with minimally invasive approaches, supporting high adoption rates across surgical specialties. South Korea has emerged as a regional leader in medical technology adoption, particularly in aesthetically oriented specialties including plastic and cosmetic surgery, where minimally invasive techniques achieve strong patient acceptance.
   

Latin America Minimally Invasive Surgical Instrument Market

The Latin American minimally invasive surgical instrument industry is anticipated to exhibit remarkable growth during the analysis period.
 

• The Latin American market is characterized by a significant private healthcare sector presence serving the urban populations. Brazil's private healthcare networks, which serve a significant percentage of the population through supplemental health insurance, drive the majority of minimally invasive surgical instrument demand, with adoption patterns approaching developed market levels in major urban centers.
   
• Mexico benefits from the proximity to the U.S. that facilitates technology transfer and creates opportunities for medical tourism. The country has developed specialized surgical facilities in border regions catering to U.S. patients seeking procedures at lower cost points, driving adoption of advanced surgical technologies.
   
• Further, regional challenges include economic volatility affecting healthcare budgets, inconsistent reimbursement frameworks, and limited access to physician training among others.
   

Middle East and Africa Minimally Invasive Surgical Instrument Market

The Middle East and Africa minimally invasive surgical instrument industry is expected to experience substantial growth over the analysis timeframe.
 

• The Gulf Cooperation Council (GCC) nations, including Saudi Arabia, the UAE, and Qatar, among others, represent well-funded healthcare systems with strong government investment in modern medical facilities.
   
• In addition, Saudi Arabia's Vision 2030 initiative includes substantial healthcare infrastructure investment, creating opportunities for medical technology suppliers as the country develops advanced tertiary care capabilities.
   
• Further, the private healthcare sector drives minimally invasive technology adoption, while public sector adoption remains limited by resource constraints in the region. However, other African markets remain largely undeveloped for advanced surgical technologies due to limited healthcare infrastructure and financial constraints.
   

Minimally Invasive Surgical Instrument Market Share

The competitive landscape of the minimally invasive surgical instrument industry is characterized by moderate competitiveness, with the top five market participants collectively holding approximately 34% market share, while numerous mid-sized and smaller specialized companies serve niche segments and specific surgical specialties.
 

In addition, the competitive landscape exhibits active strategic behavior, including mergers and acquisitions, technology licensing agreements, and collaborative development partnerships. Acquisition activity targets innovative startup companies developing novel surgical technologies, enabling established players to acquire innovation rather than relying exclusively on internal development.
 

Companies demonstrating superior clinical outcomes, efficiency improvements, and complication reductions gain competitive advantages in value-based purchasing environments. The provision of comprehensive surgeon training programs, clinical support, and equipment service creates differentiation beyond product features alone, with hospitals considering these factors in purchasing decisions.
 

Further, the emergence of domestic manufacturers in emerging markets, particularly China and India, creates new competitive pressures, particularly in price-sensitive segments. These manufacturers currently compete primarily on price rather than advanced features; hence, quality improvements and expanding product capabilities may enable these players to compete more effectively in developed markets in the coming years.
 

Minimally Invasive Surgical Instrument Market Companies

Few of the prominent players operating in the minimally invasive surgical instrument industry include:

• Abbott
• B. Braun
• Becton, Dickinson and Company
• Biorad Medisys
• Boston Scientific
• CONMED
• FUJIFILM
• Intuitive Surgical Operations
• Johnson & Johnson MedTech
• KARL STORZ
• Medtronic
• OLYMPUS
• Smith + Nephew
• Stryker
• WEXLER SURGICAL
• ZIMMER BIOMET
   

· Johnson & Johnson MedTech

Focuses on expanding robotic-assisted surgery platforms, integrating digital solutions for personalized care, and driving growth through strategic acquisitions and global presence in high-demand surgical specialties.
 

· Stryker

Prioritizes innovation in minimally invasive technologies, invests heavily in R&D for orthopedic and neuro solutions, and leverages acquisitions to strengthen product portfolio and penetrate emerging markets.
 

· Boston Scientific

Centers on portfolio diversification in endoscopy and cardiovascular MIS devices, accelerates adoption of advanced visualization tools, and pursues partnerships to expand reach in high-growth regions and new clinical areas.
 

Minimally Invasive Surgical Instrument Industry News

• In October 2025, FUJIFILM Americas announced the launch of its advanced endoscopy platform, the ELUXEO 8000 Endoscopic Imaging System. The system offers enhanced visualization through 4K resolution, triple noise reduction technology (3NR), and other key features. This product launch is expected to further improve the company's presence in the visualization system category.
   
• In October 2025, Medtronic announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform. The product is compatible with all commercially available TAVR systems for treating severe aortic stenosis. This development is expected to expand its product range and improve the company's position in the industry.
   
• In June 2025, Johnson & Johnson MedTech, a leading player in surgical technologies and solutions, announced the U.S. launch of the ETHICON 4000 Stapler. It is an advanced surgical stapler designed to manage tissue complexities and minimize risk factors for surgical leaks and bleeding complications across specialties. This development may enable the company to improve its business prospects in the coming years.
   

The minimally invasive surgical instrument market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Handheld instruments
  • Graspers
  • Retractors/elevators
  • Dilators
  • Suturing instruments
  • Other handheld instruments
• Monitoring & visualization devices
• Surgical scopes
  • Laparoscopes
  • Arthroscopes
  • Urology endoscopes
  • Neuroendoscopes
  • Other scopes
• Inflation devices
• Cutter instruments
• Guiding devices
  • Guiding catheters
  • Guidewires
• Auxiliary devices
• Electrosurgical devices

Market, By Surgery Type

• Cardiothoracic surgery
• Orthopedic surgery
• Gastrointestinal surgery
• Urological surgery
• Gynecological surgery
• Cosmetic & bariatric surgery
• Other surgery types

Market, By End Use

• Hospitals & clinics
• Ambulatory surgical centers
• Other end-users
   

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE